OMASS THERAPEUTICS LIMITED
Research and experimental development on biotechnology
OMASS THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Building 4000 John Smith Drive Oxford Business Park South Oxford OX4 2GX England
Full company profile for OMASS THERAPEUTICS LIMITED (10028228), an active life sciences and medical technology company based in Oxford, England. Incorporated 26 Feb 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2016–2025)
Cash in Bank
£39.75M
Net Assets
£31.96M
Total Liabilities
£16.64M
Turnover
£2.35M
Employees
60
Debt Ratio
34%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Dec Year End | 2024 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 4 funding rounds
Sign up to view complete fundraising history
Investors (9)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Nov 2018 | Series A |
| Investor 2 | Nov 2018 | Series A, Series B |
| Investor 3 | Feb 2020 | Series A |
See all 9 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Crespo-martin, Laia, Phd | Director | Spanish | France | 19 Apr 2022 | Active |
See all 20 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Oxford Science Enterprises Holdings Ii Limited
Unknown
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
Syncona Limited
British Channel Islands
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Oxford Science Enterprises Holdings Ii Limited
Ceased 11 Sept 2018
Oxford Sciences Innovation Plc
Ceased 11 Sept 2018
Group Structure
Group Structure
Charges
Charges
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
4000 John Smith Drive, Oxford Business Park South, Oxford (OX4 2GX) OXFORD | Leasehold | - | 23 Mar 2023 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 21 May 2026 | Officers | Termination of Magdalena Anna Jonikas as director on 19 May 2026 | |
| 21 May 2026 | Officers | Appointment of Mr Pierre-Louis Emmanuel Joffrin as director on 20 May 2026 | |
| 24 Apr 2026 | Capital | Allotment of shares (GBP 90,146.612) on 23 Apr 2026 | |
| 22 Apr 2026 | Capital | Allotment of shares (GBP 90,146.612) on 16 Apr 2026 | |
| 11 Apr 2026 | Accounts | Annual accounts made up to 31 Dec 2025 |
Termination of Magdalena Anna Jonikas as director on 19 May 2026
Appointment of Mr Pierre-Louis Emmanuel Joffrin as director on 20 May 2026
Allotment of shares (GBP 90,146.612) on 23 Apr 2026
Allotment of shares (GBP 90,146.612) on 16 Apr 2026
Annual accounts made up to 31 Dec 2025
Recent Activity
Latest Activity
Termination of Magdalena Anna Jonikas as director on 19 May 2026
2 weeks ago on 21 May 2026
Appointment of Mr Pierre-Louis Emmanuel Joffrin as director on 20 May 2026
2 weeks ago on 21 May 2026
Allotment of shares (GBP 90,146.612) on 23 Apr 2026
1 months ago on 24 Apr 2026
Allotment of shares (GBP 90,146.612) on 16 Apr 2026
1 months ago on 22 Apr 2026
Annual accounts made up to 31 Dec 2025
2 months ago on 11 Apr 2026